Concepedia

Publication | Open Access

VP6-2022: Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8.4 years' follow-up

50

Citations

0

References

2022

Year

No additional data available for this publication yet. Check back later!